353
Views
12
CrossRef citations to date
0
Altmetric
Review

Pharmacogenetics and breast cancer management: current status and perspectives

, , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Godefridus J Peters & Richard J Honeywell. (2015) Drug transport and metabolism of novel anticancer drugs. Expert Opinion on Drug Metabolism & Toxicology 11:5, pages 661-663.
Read now

Articles from other publishers (11)

Thalita Basso Scandolara, Bruno Ricardo Barreto Pires, Beatriz Vacario, Isis Salviano Soares de Amorim, Priscyanne Barreto Siqueira, Juliana Mara Serpeloni, André Luiz Mencalha, Cibele Rodrigues Bonvicino & Carolina Panis. (2022) An Overview Regarding Pharmacogenomics and Biomarkers Discovery: Focus on Breast Cancer. Current Topics in Medicinal Chemistry 22:20, pages 1654-1673.
Crossref
Sadal Refae, Jocelyn Gal, Nathalie Ebran, Josiane Otto, Delphine Borchiellini, Frederic Peyrade, Emmanuel Chamorey, Patrick Brest, Gérard Milano & Esma Saada-Bouzid. (2019) Germinal Immunogenetics predict treatment outcome for PD-1/PD-L1 checkpoint inhibitors. Investigational New Drugs 38:1, pages 160-171.
Crossref
Sadal Refae, Jocelyn Gal, Patrick Brest & Gerard Milano. (2019) Germinal immunogenetics as a predictive factor for immunotherapy. Critical Reviews in Oncology/Hematology 141, pages 146-152.
Crossref
Rekha Priyadarshini, Gerard Marshall Raj, Smita Kayal, Ananthakrishnan Ramesh & Deepak Gopal Shewade. (2019) Influence of ABCB1 C3435T and C1236T gene polymorphisms on tumour response to docetaxel-based neo-adjuvant chemotherapy in locally advanced breast cancer patients of South India . Journal of Clinical Pharmacy and Therapeutics 44:2, pages 188-196.
Crossref
Andric C. Perez-Ortiz, Israel Ramírez, Juan C. Cruz-López, Cynthia Villarreal-Garza, Alexandra Luna-Angulo, Esmeralda Lira-Romero, Salvador Jiménez-Chaidez, José Díaz-Chávez, Juan A. Matus-Santos, Laura Sánchez-Chapul, Patricia Mendoza-Lorenzo & Francisco J. Estrada-Mena. (2017) Pharmacogenetics of response to neoadjuvant paclitaxel treatment for locally advanced breast cancer. Oncotarget 8:63, pages 106454-106467.
Crossref
Maria Amélia Carlos Souto Maior Borba, Carlos Henrique Madeiros Castelletti, José Luiz de Lima Filho & Danyelly Bruneska Gondim Martins. (2017) Point-of-care devices: the next frontier in personalized chemotherapy. Future Science OA 3:3, pages FSO219.
Crossref
G. Milano. (2017) Don’t forget the host: a potential role for germinal polymorphisms as markers for checkpoint inhibitors. Annals of Oncology 28:2, pages 435-436.
Crossref
Yuval Shaked. (2016) Balancing efficacy of and host immune responses to cancer therapy: the yin and yang effects. Nature Reviews Clinical Oncology 13:10, pages 611-626.
Crossref
Hazem I. Assi, Rita E. Assi & Nagi S. El Saghir. (2016) Emerging Biomarkers of the Future: Changing Clinical Practice for 2020. Current Breast Cancer Reports 8:2, pages 60-72.
Crossref
Nicolas André, Joseph Ciccolini, Marie Amélie Heng & Eddy Pasquier. 2016. Pharmacokinetics in Drug Development. Pharmacokinetics in Drug Development 189 207 .
Keith Sacco & Godfrey Grech. (2015) Actionable pharmacogenetic markers for prediction and prognosis in breast cancer. EPMA Journal 6:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.